Oppenheimer Asset Management Inc. Has $1.40 Million Stock Holdings in Astera Labs, Inc. $ALAB

Oppenheimer Asset Management Inc. decreased its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 3.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,479 shares of the company’s stock after selling 516 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Astera Labs were worth $1,400,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. State of New Jersey Common Pension Fund D acquired a new position in shares of Astera Labs during the second quarter worth approximately $3,925,000. Sumitomo Mitsui Trust Group Inc. raised its stake in Astera Labs by 21.6% during the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock valued at $1,336,000 after purchasing an additional 2,624 shares during the last quarter. Strategic Blueprint LLC boosted its holdings in Astera Labs by 68.9% in the 2nd quarter. Strategic Blueprint LLC now owns 7,308 shares of the company’s stock valued at $661,000 after purchasing an additional 2,981 shares during the period. Ethic Inc. grew its position in Astera Labs by 234.0% in the 2nd quarter. Ethic Inc. now owns 15,811 shares of the company’s stock worth $1,439,000 after purchasing an additional 11,077 shares during the last quarter. Finally, Cookson Peirce & Co. Inc. bought a new position in shares of Astera Labs during the 2nd quarter worth about $1,270,000. 60.47% of the stock is owned by institutional investors.

Astera Labs Price Performance

Astera Labs stock opened at $169.55 on Friday. The firm has a market capitalization of $28.18 billion, a P/E ratio of 302.77, a P/E/G ratio of 4.33 and a beta of 1.43. The stock has a fifty day moving average price of $196.28 and a two-hundred day moving average price of $134.96. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.33 by $0.11. The company had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm’s revenue for the quarter was up 149.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Activity

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the sale, the director directly owned 385,863 shares of the company’s stock, valued at approximately $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jitendra Mohan sold 91,441 shares of the firm’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the sale, the chief executive officer directly owned 2,170,877 shares of the company’s stock, valued at approximately $398,377,638.27. The trade was a 4.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 1,092,997 shares of company stock valued at $192,231,120. Corporate insiders own 12.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Northland Capmk downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 22nd. Jefferies Financial Group lifted their price objective on Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a report on Tuesday, July 22nd. Susquehanna upped their target price on Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a research note on Thursday, August 7th. Finally, Morgan Stanley lifted their price target on shares of Astera Labs from $155.00 to $200.00 and gave the stock an “overweight” rating in a research note on Friday, August 29th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $162.06.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.